Emergent BioSolutions, Inc. (EBS)
8.39
+0.15
(+1.82%)
USD |
NYSE |
Jun 11, 16:00
8.39
0.00 (0.00%)
After-Hours: 18:19
Emergent BioSolutions Market Cap : 434.60M for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 426.83M |
| June 09, 2026 | 411.81M |
| June 08, 2026 | 414.40M |
| June 05, 2026 | 418.03M |
| June 04, 2026 | 437.19M |
| June 03, 2026 | 410.77M |
| June 02, 2026 | 425.28M |
| June 01, 2026 | 439.78M |
| May 29, 2026 | 472.42M |
| May 28, 2026 | 475.52M |
| May 27, 2026 | 464.37M |
| May 26, 2026 | 471.07M |
| May 22, 2026 | 435.99M |
| May 21, 2026 | 431.86M |
| May 20, 2026 | 420.51M |
| May 19, 2026 | 415.87M |
| May 18, 2026 | 419.48M |
| May 15, 2026 | 409.67M |
| May 14, 2026 | 423.61M |
| May 13, 2026 | 429.80M |
| May 12, 2026 | 438.57M |
| May 11, 2026 | 461.79M |
| May 08, 2026 | 490.16M |
| May 07, 2026 | 471.07M |
| May 06, 2026 | 469.53M |
| Date | Value |
|---|---|
| May 05, 2026 | 466.95M |
| May 04, 2026 | 440.63M |
| May 01, 2026 | 437.02M |
| April 30, 2026 | 424.64M |
| April 29, 2026 | 412.25M |
| April 28, 2026 | 424.64M |
| April 27, 2026 | 415.95M |
| April 24, 2026 | 415.72M |
| April 23, 2026 | 418.83M |
| April 22, 2026 | 429.18M |
| April 21, 2026 | 414.17M |
| April 20, 2026 | 432.29M |
| April 17, 2026 | 456.10M |
| April 16, 2026 | 446.27M |
| April 15, 2026 | 448.34M |
| April 14, 2026 | 448.34M |
| April 13, 2026 | 426.59M |
| April 10, 2026 | 412.10M |
| April 09, 2026 | 437.46M |
| April 08, 2026 | 434.36M |
| April 07, 2026 | 406.40M |
| April 06, 2026 | 419.34M |
| April 02, 2026 | 426.07M |
| April 01, 2026 | 433.84M |
| March 31, 2026 | 429.70M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.658B |
| Alnylam Pharmaceuticals, Inc. | 38.61B |
| Savara, Inc. | 1.079B |
| Vericel Corp. | 1.976B |
| Biogen, Inc. | 29.52B |
Market Cap Related Metrics
| PS Ratio | 0.6806 |
| Price to Book Value | 0.8309 |
| Price to Free Cash Flow | 3.402 |
| Price | 8.39 |
| Earnings Yield | -3.37% |
| Operating PE Ratio | 6.469 |